BridgeMD
New treatment option for Virtual Reality
Official title Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old
ClinicalTrials.gov ID: NCT05275881
What this study is testing
What is Usual Practices?
Usual Practices is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for virtual reality.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This pilot study will be testing the feasibility of medical hypnosis through virtual reality during invasive médical procédures in children and young adults with cancer. Patients age from 7 to under 25 years whose treatement protocols required a lumbure puncture and a chemotherapy by implantable venous access will be randomly assigned to virtual reality or treatement as usual (nitrous oxide, anxiolytics, opioid analgesics, psychotropic and benzodiazepine).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 24
You may be able to join if
- Patients aged 7 to strictly under 25
- Follow-ups for hematological or oncological pathology
- With a lumbar puncture or to connection to an implantable chamber
- Patient understanding French
- Consent of parents or guardians with parental authority.
You likely can't join if
- Children with cognitive impairment
- Children in absolute emergency situations
- Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy...
- Children who have already participated in the clinical investigation
- Refusal to participate in the study
- Patients not benefiting from a social security system or not benefiting from it by the intermediary of a third person
See the full eligibility criteria
- Patients aged 7 to strictly under 25
- Follow-ups for hematological or oncological pathology
- With a lumbar puncture or to connection to an implantable chamber
- Patient understanding French
- Consent of parents or guardians with parental authority.
- Child informed and having given his assent
- Children with cognitive impairment
- Children in absolute emergency situations
- Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the...
- Children who have already participated in the clinical investigation
- Refusal to participate in the study
- Patients not benefiting from a social security system or not benefiting from it by the intermediary of a third person
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.